Chapter 20 – Basic Pharmacokinetic Principles
暂无分享，去创建一个
[1] S. Joel,et al. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide. , 2002, British journal of clinical pharmacology.
[2] W. Hop,et al. Pharmacokinetics and metabolism of oral midazolam in preterm infants. , 2002, British journal of clinical pharmacology.
[3] W. Jusko,et al. Application of Moment Analysis to the Sigmoid Effect Model for Drug Administered Intravenously , 1997, Pharmaceutical Research.
[4] D. Shen,et al. First‐pass metabolism of midazolam by the human intestine , 1996, Clinical pharmacology and therapeutics.
[5] W. Jusko,et al. Noncompartmental determination of the mean residence time and steady-state volume of distribution during multiple dosing. , 1991, Journal of pharmaceutical sciences.
[6] A. Hastreiter,et al. Maintenance digoxin dosage and steady-state plasma concentration in infants and children. , 1985, The Journal of pediatrics.
[7] P Heizmann,et al. Pharmacokinetics and bioavailability of midazolam in man. , 1983, British journal of clinical pharmacology.
[8] D. Greenblatt,et al. Drug therapy. Clinical Pharmacokinetics (first of two parts). , 1975 .
[9] U. Borchard. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance. , 1990, Clinical physiology and biochemistry.
[10] G. Mccracken,et al. Clinical pharmacology and efficacy of vancomycin in pediatric patients. , 1980, The Journal of pediatrics.